WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke ColHySilic wurde als Wortmarke am 13.05.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1704443 |
| Registernummer | UK00003727358 |
| Länder | 
|
| Basismarke |
Nr. UK00003727358,
04. März 2022
|
| Anmeldedatum | 13. Mai 2022 |
| Ablaufdatum | 13. Mai 2032 |
Markeninhaber
3 Huxley Road,
Surrey Research Park
GB
Surrey Research Park
GB
Markenvertreter
Westpoint Building, James Street West
Bath BA1 2DA
GB
Waren und Dienstleistungen
01
Nanoparticle substances and nanoparticles for use in
industry, science and research; silicon for use in industry,
science and research; silicon nanoparticle materials for use
in industry, science and research; porous silicon
nanoparticle materials for use in industry, science and
research; lipid nanoparticles for use in industry, science
and research; silicon-lipid nanoparticles for use in
industry, science and research; silicon-stabilised hybrid
lipid nanoparticles for use in industry, science and
research; silicon-stabilised lipid nanoparticles for use in
industry, science and research; stabilised lipid
nanoparticles for use in industry, science and research;
chemical materials for carrying and delivery of chemical,
biochemical and biological substances; nanoparticle
materials for carrying and delivery of chemical, biochemical
and biological substances; silicon nanoparticle materials
for carrying and delivery of chemical, biochemical and
biological substances; porous silicon nanoparticle materials
for carrying and delivery of chemical, biochemical and
biological substances; lipid nanoparticle materials for
carrying and delivery of chemical, biochemical and
biological substances; silicon-lipid nanoparticle materials
for carrying and delivery of chemical, biochemical and
biological substances; silicon-stabilised hybrid lipid
nanoparticles for carrying and delivery of chemical,
biochemical and biological substances; silicon-stabilised
lipid nanoparticles for carrying and delivery of chemical,
biochemical and biological substances; stabilised lipid
nanoparticles for carrying and delivery of chemical,
biochemical and biological substances; chemical materials
for carrying and delivery of chemical, biochemical and
biological substances for use in the manufacture of
pharmaceuticals; nanoparticle materials for carrying and
delivery of chemical, biochemical and biological substances
for use in the manufacture of pharmaceuticals; silicon
nanoparticle materials for carrying and delivery of
chemical, biochemical and biological substances for use in
the manufacture of pharmaceuticals; porous silicon
nanoparticle materials for carrying and delivery of
chemical, biochemical and biological substances for use in
the manufacture of pharmaceuticals; lipid nanoparticle
materials for carrying and delivery of chemical, biochemical
and biological substances for use in the manufacture of
pharmaceuticals; silicon-lipid nanoparticle materials for
carrying and delivery of chemical, biochemical and
biological substances for use in the manufacture of
pharmaceuticals; silicon-stabilised hybrid lipid
nanoparticles for carrying and delivery of chemical,
biochemical and biological substances for use in the
manufacture of pharmaceuticals; silicon-stabilised lipid
nanoparticles for carrying and delivery of chemical,
biochemical and biological substances for use in the
manufacture of pharmaceuticals; stabilised lipid
nanoparticles for carrying and delivery of chemical,
biochemical and biological substances for use in the
manufacture of pharmaceuticals; chemical materials for
carrying and delivery of chemical, biochemical and
biological substances for use in the manufacture of
pharmaceuticals in gene therapy; nanoparticle materials for
carrying and delivery of chemical, biochemical and
biological substances for use in the manufacture of
pharmaceuticals in gene therapy; silicon nanoparticle
materials for carrying and delivery of chemical, biochemical
and biological substances for use in the manufacture of
pharmaceuticals in gene therapy; porous silicon nanoparticle
materials for carrying and delivery of chemical, biochemical
and biological substances for use in the manufacture of
pharmaceuticals in gene therapy; lipid nanoparticle
materials for carrying and delivery of chemical, biochemical
and biological substances for use in the manufacture of
pharmaceuticals in gene therapy; silicon-lipid nanoparticle
materials for carrying and delivery of chemical, biochemical
and biological substances for use in the manufacture of
pharmaceuticals in gene therapy; silicon-stabilised hybrid
lipid nanoparticles for carrying and delivery of chemical,
biochemical and biological substances for use in the
manufacture of pharmaceuticals in gene therapy;
silicon-stabilised lipid nanoparticles for carrying and
delivery of chemical, biochemical and biological substances
for use in the manufacture of pharmaceuticals in gene
therapy; stabilised lipid nanoparticles for carrying and
delivery of chemical, biochemical and biological substances
for use in the manufacture of pharmaceuticals in gene
therapy; chemical materials for carrying and delivery of
chemical, biochemical and biological substances for use in
the manufacture of vaccines; nanoparticle materials for
carrying and delivery of chemical, biochemical and
biological substances for use in the manufacture of
vaccines; silicon nanoparticle materials for carrying and
delivery of chemical, biochemical and biological substances
for use in the manufacture of vaccines; porous silicon
nanoparticle materials for carrying and delivery of
chemical, biochemical and biological substances for use in
the manufacture of vaccines; lipid nanoparticle materials
for carrying and delivery of chemical, biochemical and
biological substances for use in the manufacture of
vaccines; silicon-lipid nanoparticle materials for carrying
and delivery of chemical, biochemical and biological
substances for use in the manufacture of vaccines;
silicon-stabilised hybrid lipid nanoparticles for carrying
and delivery of chemical, biochemical and biological
substances for use in the manufacture of vaccines;
silicon-stabilised lipid nanoparticles for carrying and
delivery of chemical, biochemical and biological substances
for use in the manufacture of vaccines; stabilised lipid
nanoparticles for carrying and delivery of chemical,
biochemical and biological substances for use in the
manufacture of vaccines; chemical materials for stabilising
of chemical, biochemical and biological substances;
nanoparticle materials for stabilising of chemical,
biochemical and biological substances; silicon nanoparticle
materials for stabilising of chemical, biochemical and
biological substances; porous silicon nanoparticle materials
for stabilising of chemical, biochemical and biological
substances; lipid nanoparticle materials for stabilising of
chemical, biochemical and biological substances;
silicon-lipid nanoparticle materials for stabilising of
chemical, biochemical and biological substances;
silicon-stabilised hybrid lipid nanoparticles for
stabilising of chemical, biochemical and biological
substances; silicon-stabilised lipid nanoparticles for
stabilising of chemical, biochemical and biological
substances; stabilised lipid nanoparticles for stabilising
of chemical, biochemical and biological substances; chemical
materials for stabilising nucleic acids; nanoparticle
materials for stabilising nucleic acids; silicon
nanoparticle materials for stabilising nucleic acids; porous
silicon nanoparticle materials for stabilising nucleic
acids; lipid nanoparticle materials for stabilising nucleic
acids; silicon-lipid nanoparticle materials for stabilising
nucleic acids; silicon-stabilised hybrid lipid nanoparticles
for stabilising nucleic acids; silicon-stabilised lipid
nanoparticles for stabilising nucleic acids; stabilised
lipid nanoparticles for stabilising nucleic acids; chemical
materials for stabilising nucleic acid-lipid complexes;
nanoparticle materials for stabilising nucleic acid-lipid
complexes; silicon nanoparticle materials for stabilising
nucleic acid-lipid complexes; porous silicon nanoparticle
materials for stabilising of nucleic acid-lipid complexes;
lipid nanoparticle materials for stabilising nucleic
acid-lipid complexes; silicon-lipid nanoparticle materials
for stabilising nucleic acid-lipid complexes;
silicon-stabilised hybrid lipid nanoparticles for
stabilising nucleic acid-lipid complexes; silicon-stabilised
lipid nanoparticles for stabilising nucleic acid-lipid
complexes; stabilised lipid nanoparticles for stabilising
nucleic acid-lipid complexes
05
Nanoparticle substances and nanoparticle preparations for
medical, veterinary and pharmaceutical purposes; silicon
nanoparticle substances and silicon nanoparticle
preparations for medical, veterinary and pharmaceutical
purposes; porous silicon nanoparticle substances and porous
silicon nanoparticle preparations for medical, veterinary
and pharmaceutical purposes; lipid nanoparticle substances
and lipid nanoparticle preparations for medical, veterinary
and pharmaceutical purposes; silicon-lipid nanoparticle
substances and silicon-lipid nanoparticle preparations for
medical, veterinary and pharmaceutical purposes;
silicon-stabilised hybrid lipid nanoparticles for medical,
veterinary and pharmaceutical purposes; silicon-stabilised
lipid nanoparticles for medical, veterinary and
pharmaceutical purposes; stabilised lipid nanoparticles for
medical, veterinary and pharmaceutical purposes;
nanoparticle substances and nanoparticle preparations for
pharmaceutical, medical and veterinary diagnosis purposes;
silicon nanoparticle substances and silicon nanoparticle
preparations for pharmaceutical, medical and veterinary
diagnosis purposes; porous silicon nanoparticle substances
and porous silicon nanoparticle preparations for
pharmaceutical, medical and veterinary diagnosis purposes;
lipid nanoparticle substances and lipid nanoparticle
preparations for pharmaceutical, medical and veterinary
diagnosis purposes; silicon-lipid nanoparticle substances
and silicon-lipid nanoparticle preparations for
pharmaceutical, medical and veterinary diagnosis purposes;
silicon-stabilised hybrid lipid nanoparticles for
pharmaceutical, medical and veterinary diagnosis purposes;
silicon-stabilised lipid nanoparticles for pharmaceutical,
medical and veterinary diagnosis purposes; stabilised lipid
nanoparticles for pharmaceutical, medical and veterinary
diagnosis purposes; nanoparticle substances and nanoparticle
preparations for medical, veterinary and pharmaceutical
treatment purposes; silicon nanoparticle substances and
silicon nanoparticle preparations for medical, veterinary
and pharmaceutical treatment purposes; porous silicon
nanoparticle substances and porous silicon nanoparticle
preparations for medical, veterinary and pharmaceutical
treatment purposes; lipid nanoparticle substances and lipid
nanoparticle preparations for medical, veterinary and
pharmaceutical treatment purposes; silicon-lipid
nanoparticle substances and lipid nanoparticle preparations
for medical, veterinary and pharmaceutical treatment
purposes; silicon-stabilised hybrid lipid nanoparticles for
medical, veterinary and pharmaceutical treatment purposes;
silicon-stabilised lipid nanoparticles for medical,
veterinary and pharmaceutical treatment purposes; stabilised
lipid nanoparticles for medical, veterinary and
pharmaceutical treatment purposes; pharmaceutical
preparations for carrying and delivery of chemical,
biochemical, biological and pharmaceutical substances;
pharmaceutical nanoparticle preparations for carrying and
delivery of chemical, biochemical, biological and
pharmaceutical substances; pharmaceutical silicon
nanoparticle preparations for carrying and delivery of
chemical, biochemical, biological and pharmaceutical
substances; pharmaceutical porous silicon nanoparticle
preparations for carrying and delivery of chemical,
biochemical, biological and pharmaceutical substances; lipid
nanoparticles being pharmaceutical preparations for carrying
and delivery of chemical, biochemical, biological and
pharmaceutical substances; silicon-lipid nanoparticles being
pharmaceutical preparations for carrying and delivery of
chemical, biochemical, biological and pharmaceutical
substances; silicon-stabilised hybrid lipid nanoparticles
being pharmaceutical preparations for carrying and delivery
of chemical, biochemical, biological and pharmaceutical
substances; silicon-stabilised lipid nanoparticles being
pharmaceutical preparations for carrying and delivery of
chemical, biochemical, biological and pharmaceutical
substances; stabilised lipid nanoparticles being
pharmaceutical preparations for carrying and delivery of
chemical, biochemical, biological and pharmaceutical
substances; pharmaceutical preparations for stabilising of
chemical, biochemical, biological and pharmaceutical
substances; pharmaceutical nanoparticle preparations for
stabilising of chemical, biochemical, biological and
pharmaceutical substances; pharmaceutical silicon
nanoparticle preparations for stabilising of chemical,
biochemical, biological and pharmaceutical substances;
pharmaceutical porous silicon nanoparticle preparations for
stabilising of chemical, biochemical, biological and
pharmaceutical substances; lipid nanoparticles being
pharmaceutical preparations for stabilising of chemical,
biochemical, biological and pharmaceutical substances;
silicon-lipid nanoparticles being pharmaceutical
preparations for stabilising of chemical, biochemical,
biological and pharmaceutical substances; silicon-stabilised
hybrid lipid nanoparticles being pharmaceutical preparations
for stabilising of chemical, biochemical, biological and
pharmaceutical substances; silicon-stabilised lipid
nanoparticles being pharmaceutical preparations for
stabilising of chemical, biochemical, biological and
pharmaceutical substances; stabilised lipid nanoparticles
being pharmaceutical preparations for stabilising of
chemical, biochemical, biological and pharmaceutical
substances; pharmaceutical preparations for stabilising
nucleic acids; pharmaceutical nanoparticle preparations for
stabilising nucleic acids; pharmaceutical silicon
nanoparticle preparations for stabilising nucleic acids;
pharmaceutical porous silicon nanoparticle preparations for
stabilising nucleic acids; lipid nanoparticles being
pharmaceutical preparations for stabilising nucleic acids;
silicon-lipid nanoparticles being pharmaceutical
preparations for stabilising nucleic acids;
silicon-stabilised hybrid lipid nanoparticles being
pharmaceutical preparations for stabilising nucleic acids;
silicon-stabilised lipid nanoparticles being pharmaceutical
preparations for stabilising nucleic acids; stabilised lipid
nanoparticles being pharmaceutical preparations for
stabilising nucleic acids; pharmaceutical preparations for
stabilising nucleic acid-lipid complexes; pharmaceutical
nanoparticle preparations for stabilising nucleic acid-lipid
complexes; pharmaceutical silicon nanoparticle preparations
for stabilising nucleic acid-lipid complexes; pharmaceutical
porous silicon nanoparticle preparations for stabilising
nucleic acid-lipid complexes; lipid nanoparticles being
pharmaceutical preparations for stabilising nucleic
acid-lipid complexes; silicon-lipid nanoparticles being
pharmaceutical preparations for stabilising nucleic
acid-lipid complexes; silicon-stabilised hybrid lipid
nanoparticles being pharmaceutical preparations for
stabilising nucleic acid-lipid complexes; silicon-stabilised
lipid nanoparticles being pharmaceutical preparations for
stabilising nucleic acid-lipid complexes; stabilised lipid
nanoparticles being pharmaceutical preparations for
stabilising nucleic acid-lipid complexes; pharmaceutical
preparations for controlled release and onset of chemical,
biochemical, biological and pharmaceutical substances;
pharmaceutical nanoparticle preparations for controlled
release and onset of chemical, biochemical, biological and
pharmaceutical substances; pharmaceutical silicon
nanoparticle preparations for controlled release and onset
of chemical, biochemical, biological and pharmaceutical
substances; pharmaceutical porous silicon nanoparticle
preparations for controlled release and onset of chemical,
biochemical, biological and pharmaceutical substances; lipid
nanoparticle materials being pharmaceutical preparations for
controlled release and onset of chemical, biochemical,
biological and pharmaceutical substances; silicon-lipid
nanoparticle materials being pharmaceutical preparations for
controlled release and onset of chemical, biochemical,
biological and pharmaceutical substances; silicon-stabilised
hybrid lipid nanoparticles being pharmaceutical preparations
for controlled release and onset of chemical, biochemical,
biological and pharmaceutical substances; silicon-stabilised
lipid nanoparticles being pharmaceutical preparations for
controlled release and onset of chemical, biochemical,
biological and pharmaceutical substances; stabilised lipid
nanoparticles being pharmaceutical preparations for
controlled release and onset of chemical, biochemical,
biological and pharmaceutical substances; pharmaceutical
preparations for controlled release and transfection of
nucleic acids; pharmaceutical nanoparticle preparations for
controlled release and transfection of nucleic acids;
pharmaceutical silicon nanoparticle preparations for
controlled release and transfection of nucleic acids;
pharmaceutical porous silicon nanoparticle preparations for
controlled release and transfection of nucleic acids; lipid
nanoparticle materials being pharmaceutical preparations for
controlled release and transfection of nucleic acids;
silicon-lipid nanoparticle materials being pharmaceutical
preparations for controlled release and transfection of
nucleic acids; silicon-stabilised hybrid lipid nanoparticles
being pharmaceutical preparations for controlled release and
transfection of nucleic acids; silicon-stabilised lipid
nanoparticles being pharmaceutical preparations for
controlled release and transfection of nucleic acids;
stabilised lipid nanoparticles being pharmaceutical
preparations for controlled release and transfection of
nucleic acids
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 01. Juni 2023 | 2023/22 Gaz | CN | Ablehnung |
| 22. Mai 2023 | 2023/21 Gaz | EM | Ablehnung |
| 26. April 2023 | 2023/17 Gaz | US | Ablehnung |
| 13. Mai 2022 | 2022/50 Gaz | GB | Eintragung |
ID: 141704443